(Q37789472)

23 August 2017

title

Alterations in dopamine and glutamate neurotransmission in tetrahydrobiopterin deficient spr-/- mice: relevance to schizophrenia (English)

1 reference

23 August 2017

0 references

0 references

1 reference

Yong Kee Choi

1

1 reference

23 August 2017

Frank I. Tarazi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20846490

14 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20846490

14 July 2024

publication date

1 September 2010

1 reference

full work available at URL

23 August 2017

http://society.kisti.re.kr/sv/SV_svpsbs03V.do?method=download&cn1=JAKO201028552429149

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20846490

http://ocean.kisti.re.kr/downfile/crosscheck/ksbmb/JAKO201028552429149.pdf

14 July 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

14 July 2024

1 reference

23 August 2017

volume

43

1 reference

23 August 2017

issue

9

1 reference

23 August 2017

page(s)

593-598

1 reference

23 August 2017

1

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

14 July 2024

2

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia

14 July 2024

3

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

14 July 2024

4

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Provocative tests with psychostimulant drugs in schizophrenia

14 July 2024

5

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics

14 July 2024

6

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment

14 July 2024

7

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Repeated antipsychotic drug exposure in developing rats: dopamine receptor effects

14 July 2024

8

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Effects of risperidone on dopamine receptor subtypes in developing rat brain

14 July 2024

9

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Glutamatergic mechanisms in schizophrenia

14 July 2024

10

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Working memory deficit as a core neuropsychological dysfunction in schizophrenia

14 July 2024

11

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Mice with reduced NMDA receptor expression display behaviors related to schizophrenia

14 July 2024

12

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Glutamate receptor expression in schizophrenic brain

14 July 2024

13

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Regulation of ionotropic glutamate receptors following subchronic and chronic treatment with typical and atypical antipsychotics

14 July 2024

15

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Effect of chronic clozapine administration on [3H]MK801-binding sites in the rat brain: a side-preference action in cortical areas.

14 July 2024

16

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Antipsychotic drug regulation of AMPA receptor affinity states and GluR1, GluR2 splice variant expression

14 July 2024

17

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Differential effects of haloperidol and clozapine on ionotropic glutamate receptors in rats

14 July 2024

18

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Regulation of NMDA receptor subunit messenger RNA levels in the rat brain following acute and chronic exposure to antipsychotic drugs

14 July 2024

19

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Clozapine and haloperidol differentially affect AMPA and kainate receptor subunit mRNA levels in rat cortex and striatum

14 July 2024

20

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Tetrahydrobiopterin biosynthesis, regeneration and functions

14 July 2024

21

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Human carbonyl and aldose reductases: new catalytic functions in tetrahydrobiopterin biosynthesis

14 July 2024

22

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

THE STRUCTURE OF THE PHENYLALANINE-HYDROXYLATION COFACTOR

14 July 2024

23

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Catecholamines and serotonin are differently regulated by tetrahydrobiopterin. A study from 6-pyruvoyltetrahydropterin synthase knockout mice

14 July 2024

24

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

A murine model for human sepiapterin-reductase deficiency

14 July 2024

25

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Tetrahydrobiopterin Prevents Nitration of Tyrosine Hydroxylase by Peroxynitrite and Nitrogen Dioxide

14 July 2024

26

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy

14 July 2024

27

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy

14 July 2024

28

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Novel neurotransmitters and their neuropsychiatric relevance

14 July 2024

29

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Synaptic signaling by nitric oxide

14 July 2024

30

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Role of nitric oxide in the regulation of monoaminergic neurotransmission

14 July 2024

31

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

6R-tetrahydrobiopterin perfusion enhances dopamine, serotonin, and glutamate outputs in dialysate from rat striatum and frontal cortex

14 July 2024

32

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Enhancement of dopamine release in vivo from the rat striatum by dialytic perfusion of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin

14 July 2024

33

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

The regulation of dopamine release from striatum slices by tetrahydrobiopterin and L-arginine-derived nitric oxide

14 July 2024

34

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Effect of Tetrahydrobiopterin on Serotonin Synthesis, Release, and Metabolism in Superfused Hippocampal Slices

14 July 2024

35

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Cerebrospinal fluid hydroxylase cofactor in schizophrenia

14 July 2024

36

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Urinary excretion of biopterin and neopterin in psychiatric disorders

14 July 2024

37

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Biopterin derivatives in human body fluids and tissues

14 July 2024

38

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Evidence for a tetrahydrobiopterin deficit in schizophrenia

14 July 2024

39

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Analysis of plasma biopterin levels in psychiatric disorders suggests a common BH4 deficit in schizophrenia and schizoaffective disorder.

14 July 2024

40

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls

14 July 2024

41

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Low HVA and normal 5HIAA CSF levels in drug-free schizophrenic patients compared to healthy volunteers: correlations to symptomatology and family history

14 July 2024

42

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

CSF monoamine metabolites in schizophrenic patients

14 July 2024

43

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Reduced tyrosine hydroxylase and GTP cyclohydrolase mRNA expression, tyrosine hydroxylase activity, and associated neurochemical alterations in Nurr1-null heterozygous mice

14 July 2024

44

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Reduction of dopamine-related transcription factors Nurr1 and NGFI-B in the prefrontal cortex in schizophrenia and bipolar disorders

14 July 2024

45

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Molecular, functional and biochemical characteristics of the dopamine transporter: regional differences and clinical relevance

14 July 2024

46

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

14 July 2024

47

1 reference

https://api.crossref.org/works/10.5483/BMBREP.2010.43.9.593

14 July 2024

Identifiers

1 reference

23 August 2017

1 reference